Literature DB >> 6950412

Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.

J H Sher, A Stracher, S A Shafiq, J Hardy-Stashin.   

Abstract

Mice with genetic muscular dystrophy were treated with intraperitoneal injections of the proteinase inhibitor leupeptin, beginning before the onset of weakness. A significant number of the treated animals failed to develop histological evidence of dystrophy, compared with controls. Leupeptin treatment prevented (or delayed) the onset of muscular dystrophy in this experiment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6950412      PMCID: PMC349346          DOI: 10.1073/pnas.78.12.7742

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Biochemistry of dystrophic muscle. 2. Some enzyme changes in dystrophic mouse muscle.

Authors:  R J Pennington
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.

Authors:  E B McGowan; S A Shafiq; A Stracher
Journal:  Exp Neurol       Date:  1976-03       Impact factor: 5.330

3.  Cathepsins A, B, C, D and autolysis during development of breast muscle of normal and dystrophic chickens.

Authors:  A A Iodice; J Chin; S Perker; I M Weinstock
Journal:  Arch Biochem Biophys       Date:  1972-09       Impact factor: 4.013

4.  Muscular dystrophy in the mouse caused by an allele at the dy-locus.

Authors:  H Meier; J L Southard
Journal:  Life Sci       Date:  1970-02-08       Impact factor: 5.037

5.  Relevance of genetic animal models of muscular dystrophy to human muscular dystrophies.

Authors:  J R Mendell; R Higgins; Z Sahenk; E Cosmos
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

6.  Ultrastructural localization of calcium in normal and abnormal skeletal muscle.

Authors:  M A Oberc; W K Engel
Journal:  Lab Invest       Date:  1977-06       Impact factor: 5.662

7.  Removal of Z-lines and alpha-actinin from isolated myofibrils by a calcium-activated neutral protease.

Authors:  M K Reddy; J D Etlinger; M Rabinowitz; D A Fischman; R Zak
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

Review 8.  Biochemistry of muscle membranes in Duchenne muscular dystrophy.

Authors:  L P Rowland
Journal:  Muscle Nerve       Date:  1980 Jan-Feb       Impact factor: 3.217

9.  Freeze-fracture study of muscle plasmalemma in normal and dystrophic chickens.

Authors:  B R Costello; S A Shafiq
Journal:  Muscle Nerve       Date:  1979 May-Jun       Impact factor: 3.217

10.  Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.

Authors:  A Stracher; E B McGowan; S A Shafiq
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

View more
  4 in total

1.  Isolation and characterization of cathepsin B from bovine brain.

Authors:  J D Bradley; J N Whitaker
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

2.  Effects of the protease inhibitor leupeptin on proteolytic activities and regeneration of mouse skeletal muscles after exercise injuries.

Authors:  A Salminen
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

Review 3.  Proteases of human brain.

Authors:  A Pope; R A Nixon
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

4.  Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study.

Authors:  I Nonaka; S Ishiura; A Takagi; H Sugita
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.